A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy

Cornell University A2201, New York

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

Univ. of Rochester ACTG CRS, Rochester

Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.

Johns Hopkins Adult AIDS CRS, Baltimore

Alabama Therapeutics CRS, Birmingham

Methodist Hosp. of Indiana, Indianapolis

University of Minnesota, ACTU, Minneapolis

Washington U CRS, St Louis

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Queens Med. Ctr., Honolulu

Univ. of Miami AIDS CRS, Miami

The Ohio State Univ. AIDS CRS, Columbus

Univ. of Cincinnati CRS, Cincinnati

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

University of Washington AIDS CRS, Seattle

USC CRS, Los Angeles

Stanford CRS, Palo Alto

Ucsd, Avrc Crs, San Diego

Ucsf Aids Crs, San Francisco

University of Colorado Hospital CRS, Aurora

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

Beth Israel Med. Ctr. (Mt. Sinai), New York

Memorial Sloan-Kettering Cancer Ctr., New York

NY Univ. HIV/AIDS CRS, New York

Case CRS, Cleveland

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

Massachusetts General Hospital ACTG CRS, Boston

Bmc Actg Crs, Boston

Beth Israel Deaconess - East Campus A0102 CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Puerto Rico-AIDS CRS, San Juan